(Earlier research found that a higher 4.5-mg dose of cagrilintide led to 10% weight loss after 26 weeks in adults without diabetes.) But combining the two peptides and tackling appetite hormones from different but complementary angles appears to be more effective than either peptide alone
Vomiting rates with cagrilintide monotherapy were significantly lower than with GLP-1 receptor agonists
A minimum of 8 weeks appears necessary to observe meaningful changes in chronic conditions, with 10 to 12 week cycles common
Cardiovasc Res 89(2):309319 Hao E, Mukhopadhyay P, Cao Z, Erdlyi K, Holovac E, Liaudet L, Lee WS, Hask G, Mechoulam R, Pacher P (2015) Cannabidiol protects against doxorubicin-induced cardiomyopathy by modulating mitochondrial function and biogenesis
A proper workup matters because plans differ a lot